Compare Nvidia Corp (NVDA) vs Twist Bioscience Corp (TWST) Price & Performance

Nvidia CorpTrade

Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Nvidia Corp vs Twist Bioscience Corp — how do they compare? Nvidia Corp trades at $206.59 (market cap $4.92T), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Nvidia Corp is far larger — about 902.8× Twist Bioscience Corp's market cap, and Nvidia Corp pays a 0.49% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

	NVDA	TWST
Market Cap	$4.92T	$5.45B
Sector	Technology	Health
52-Week High	$235.75	$102.88
52-Week Low	$165.17	$24.16
Enterprise Value	$4.86T	$5.37B
Dividend Yield	0.49%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nvidia Corp

Nvidia (NVDA) trades at $207.14, up 2.14% today, with a neutral technical signal and strong fundamental performance. Recent earnings consistently beat estimates, with Q1 2026 EPS of $1.87 exceeding the $1.76 forecast. Revenue surged to $130.50B in 2025, driving a net income margin of 62.97%. The stock faces resistance near $210, while support holds at $201.

Outlook remains positive due to AI-driven growth and robust profitability, but risks include peak AI spending concerns and competitive pressures. Analysts project a $325.86 price target, with 75% recommending Buy. Investors should weigh high valuation multiples against sustained earnings momentum.

Twist Bioscience Corp

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVDA

Amplify CWP Growth & Income ETF offers 10.69% yield with tech focus, rated a BUY for income portfolios.Seeking Alpha · 6 hours agoBullish Roundhill Magnificent Seven ETF offers equal exposure to top 7 mega-cap tech stocks but with higher risk and cost.24/7 Wall Street · 6 hours agoNeutral Nvidia faces pressure from cheaper Chinese chips but bets on AI and emerging tech for growthSeeking Alpha · 7 hours agoNeutral View details →

TWST

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral View details →

About Nvidia Corp

NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.